Merck Foundation and Marshall Health announce new initiative to address opioid epidemic in West Virginia

In a recent news release, Merck announced its new initiative to address opiod epidemic in West Virginia. 

The Merck Foundation (the Foundation) is supporting a new initiative with Marshall Health to launch the Great Rivers Regional System for Addiction Care (the System) to address areas hit hardest by the opioid epidemic in West Virginia.

With a $2 million grant from the Foundation payable over four years, the System is an innovative, comprehensive approach that aims to reduce opioid overdoses and overdose deaths, improve access to substance abuse prevention and treatment services, and help reduce the rising rates of HIV and hepatitis C infections. Learn more about Merck’s commitment.

“Opioid overdose is the leading cause of death for Americans under 50, and opioid use contributes to a significant increase in infectious diseases, including HIV and hepatitis C,” said Dr. Julie L. Gerberding, chief patient officer, Merck and vice chair, Merck Foundation Board of Trustees. “We have a long history of addressing public health challenges and we’re proud to be the first private-sector partner to join with Marshall Health and others to find effective solutions to this deadly epidemic.”

Editor's Note: this news release originally appeared on Merck's website

To view the full news release, click here

News from our Partners 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars